2015, Number 2
Bacteriological behavior of chronic otitis media in patients diagnosed in Otorhinolaryngology Service
Language: Spanish
References: 17
Page: 11-18
PDF size: 142.05 Kb.
ABSTRACT
Introduction: chronic otitis media is still an important cause of morbidity and hearing impairment in children and adults worldwide. The choice of antibiotic treatment in different stages of chronic otitis media is constantly being revised due to possible variations in antibiotic susceptibility of organisms involved. Objective: describe the bacteriological behavior of chronic otitis media in “Dr. Antonio Luaces Iraola” Universitary Hospital of Ciego de Ávila where, from March 2011 to December 2013, an observational descriptive cross-sectional study of patients diagnosed with chronic otitis media was carried out. Results: the highest incidence of the disease was in the ages of 6-15 years. Bacteriological behavior occurs as follows: germs such as Pseudomonas aeruginosa, Escherichia coli and Proteus were the bacteria most frequently found, followed by Staphylococcus aureus and Klepsiella. Antibiotics with more sensitive were amikacin, being sensitive in 148 cases, gentamicin, kanamycin, chloramphenicol, claforan (cefotaxime), rocephin (ceftriaxone), norfloxacin and sulfaprin. Antibiotics with increased antimicrobial resistance as the most common germs were: Peudomonas aeruginosa: ampicillin, kanamycin, chloramphenicol and sulfaprin. Escherichia coli: ampicillin and sulfaprin. Proteus mirabilis: ampicillin, kanamycin, chloramphenicol and sulfaprín. Staphylococcus aureus: ampicillin and erythromycin. Klepsiella: ampicillin, rocephin and claforan. Conclusions: a high incidence of chronic otitis media just as well as a variety of germs with sensitivity and resistance to antimicrobial therapy was found.REFERENCES
Quintero Noa JL, Álvarez Lam I, Hernández Cordero MC, Meléndez Quintero LL. Complicaciones de las otitis medias agudas y crónicas en el niño. Rev Cubana Pediatr [Internet]. Mar 2013 [citado 12 Dic 2013];85(1):89-105. Disponible en: http://scielo.sld.cu/s cielo.php?script=sci_arttext&pid=S0034-75312013000100009&lng=es.
Quintero Noa JL, Álvarez Lam I, Hernández Cordero MC, Meléndez Quintero LL. Complicaciones de las otitis medias agudas y crónicas en el niño. Rev Cubana Pediatr [Internet]. Mar 2013 [citado 28 Ene 2014];85(1):89-105. Disponible en: http://scieloprueba.s ld.cu/scielo.php?script=sci_arttext&pid=S0034-75312013000100009&lng=es.
Álvarez Lam I, Quintero Noa J, Villavicencio Cordovés E, Ponce Bittar J, Tamargo Martínez I, Quiñones Pérez D, et al. Caracterización clínico-epidemiológica de la otitis media aguda en pacientes pediátricos. Rev Cubana Pediatr [Internet]. Sep 2011 [citado 30 Dic 2014];83(3):271-79. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0 034-75312011000300006&lng=es.
Castillo Martín F, Baquero Artigao F, Calle Cabrera T, López Robles M, Ruiz Canela Cáceres J, Alfayate Miguélez S, et al. Documento de consenso sobre etiología, diagnóstico y tratamiento de la otitis media aguda. Rev Pediatr Aten Primaria [Internet]. Sep 2012 [citado 30 Ene 2014];14(55):195-205. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid =S1139-76322012000400002&lng=es.
Barajas Viracachá NC. Prevalencia de serotipos de Streptococcus pneumoniae y otros gérmenes causantes de otitis media aguda en niños de Latinoamérica: Revisión sistemática de la bibliografía. Arch Argent Pediatr [Internet]. 2011 [citado 12 Dic 2014];109(3):[aprox. 8 p.]. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-007520 11000300004&lng=es&nrm=iso
Isla A, Trocónizb IF, Canutc A, Laborac A, Martín Herrerod JE, Pedraza JL, et al. Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain. Enferm Infecc Microbiol Clin [Internet]. 2011 [citado 12 Nov 2014];29(3):167–73. Disponible en: http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=90001763&pident_usua rio=0&pcontactid=&pident_revista=28&ty=17&accion=L&origen=elsevier&web=www.elsevier .es&lan=en&fichero=28v29n03a90001763pdf001.pdf
Álvarez Amador HE, García García EG, Santana Álvarez J, Castillo Toledo L, Iglesias Soliz JM. Uso de ceftriaxona en monodosis para el tratamiento de la otitis media aguda supurada en pacientes de edad pediátrica. AMC [Internet]. Feb 2011 [citado 31 Dic 2014];15(1):1-11. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552011000100 010&lng=es.